Oxidized thioether derivatives of styrylazoles and their use as HER tyrosine kinases inhibitors

Details for Australian Patent Application No. 2005229351 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Kling, Lothar; Friess, Thomas; Bossenmaier, Birgit; Rueth, Matthias; Friebe, Walter-Gunar; Voss, Edgar

Agent Davies Collison Cave

Pub. Number AU-A-2005229351

PCT Pub. Number WO2005/095393

Priority 04005274.8 05.03.04 EP

Filing date 4 March 2005

Wipo publication date 13 October 2005

International Classifications

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

24 August 2006 PCT application entered the National Phase

  PCT publication WO2005/095393 Priority application(s): WO2005/095393

12 March 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005229352-Pentafluorosulfanyl compounds, their manufacture and use as pharmaceutical agents

2005229347-LLDPE pressure pipe